Literature DB >> 34464545

Recent insights into the pathogenesis of autoimmune hypophysitis.

Francesco Frasca1, Tommaso Piticchio1, Rosario Le Moli1, Roberta Malaguarnera2, Alfredo Campennì3, Salvatore Cannavò4,5, Rosaria Maddalena Ruggeri4,6.   

Abstract

INTRODUCTION: Hypophysitis is an inflammation of the pituitary gland and a rare case of hypopituitarism. Despite the expanding spectrum of histological variants and causative agents, its pathogenesis is far to be fully understood. The present review is focused on recent evidence concerning the pathogenesis of autoimmune hypophysitis by searching through online databases like MEDLINE and Scopus up to May 2021. AREAS COVERED: Hypophysitis frequently develops in the context of a strong autoimmune background, including a wide spectrum of subtypes ranging from the commonest form of lymphocytic hypophysitis to the newly described and less common IgG4-, anti-PIT-1, and ICI-induced forms. A peculiar combination of genetic predisposition, pituitary damage and immunological setting represents the pathogenetic basis of autoimmune hypophysitis, which is characterized by diffuse infiltration of the gland by lymphocytes and variable degrees of fibrosis followed by pituitary cell destruction. Anti-pituitary antibodies (APA) have been described in sera from patients suffering from autoimmune hypophysitis, though their pathophysiological significance remains largely unknown and their diagnostic value limited. EXPERT OPINION: In recent years hypophysitis has gained interest due to the increased number of new diagnoses and the recognition of novel subtypes. Further studies could lead to improvements in biochemical/immunological diagnosis and targeted treatments.

Entities:  

Keywords:  Autoimmunity; anti-pit-1 hypophysitis-igg4-related hypophysitis; ctla-4; hypothalamitis; immune checkpoint inhibitors; lymphocytic hypophysitis; pituitary

Mesh:

Substances:

Year:  2021        PMID: 34464545     DOI: 10.1080/1744666X.2021.1974297

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  2 in total

1.  Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results.

Authors:  Sabrina Chiloiro; Ettore Domenico Capoluongo; Flavia Angelini; Feliciana Mariotti; Giuseppe Grande; Egidio Stigliano; Federica Vincenzoni; Antonio Bianchi; Antonella Giampietro; Domenico Milardi; Tommaso Tartaglione; Andrea Urbani; Alfredo Pontecorvi; Laura De Marinis; Giovanni Di Zenzo
Journal:  Endocrine       Date:  2021-11-19       Impact factor: 3.925

2.  Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review.

Authors:  Min Li; Chenchen Wu; Yan Liu; Ranran Zhang; Qingqing Yang; Zhaoming Shi; Weihua Sun; Xiaolei Hu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-22       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.